BOOST study (stem cell infusion for MI)

From Aaushi
Jump to navigation Jump to search
[1]

Introduction

Study characteristics: 60 patients

Autologous bone marrow stem cells infused into revascularized coronary arteries after myocardial infarction, 5 days after revascularization.

Group receiving stem cells had 6% higher LVEF than controls after 6 months.

No difference in rates of ventricular ectopy or restenosis.

More general terms

References

  1. ↑ Journal Watch 24(16):126, 2004 Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004 Jul 10;364(9429):141-8. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15246726
Retrieved from "https://aaushi.info/w/index.php?title=A7728&oldid=926192"